Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SPERDUTI, Isabella")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 33

  • Page / 2
Export

Selection :

  • and

Increased incidence of thyroid cancer in Latina, Italy: A possible role of detection of subclinical diseaseBUSCO, Susanna; GIORGI ROSSI, Paolo; SPERDUTI, Isabella et al.Cancer epidemiology (Print). 2013, Vol 37, Num 3, pp 262-269, issn 1877-7821, 8 p.Article

INFLUENCE OF INTENSITY-MODULATED RADIATION THERAPY TECHNIQUE ON XEROSTOMIA AND RELATED QUALITY OF LIFE IN PATIENTS TREATED WITH INTENSITY-MODULATED RADIATION THERAPY FOR NASOPHARYNGEAL CANCERMARUCCI, Laura; MARZI, Simona; SPERDUTI, Isabella et al.Head & neck. 2012, Vol 34, Num 3, pp 328-335, issn 1043-3074, 8 p.Article

Does Hormone Treatment Added to Radiotherapy Improve Outcome in Locally Advanced Prostate Cancer?: Meta-Analysis of Randomized TrialsBRIA, Emilio; CUPPONE, Federica; GIANNARELLI, Diana et al.Cancer. 2009, Vol 115, Num 15, pp 3446-3456, issn 0008-543X, 11 p.Article

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancerBRIA, Emilio; MILELLA, Michele; MARCHETTI, Antonio et al.Lung cancer. 2009, Vol 66, Num 3, pp 365-371, issn 0169-5002, 7 p.Conference Paper

Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer : the dark side of the moon? A meta-analysis of the randomized trialsBRIA, Emilio; CUPPONE, Federica; FORMER, Monica et al.Breast cancer research and treatment. 2008, Vol 109, Num 2, pp 231-239, issn 0167-6806, 9 p.Article

Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer : Meta-analysis of randomized clinical trialsBRIA, Emilio; GRALLA, Richard J; RAFTOPOULOS, Harry et al.Lung cancer. 2009, Vol 63, Num 1, pp 50-57, issn 0169-5002, 8 p.Article

Transradial access compared with femoral puncture closure devices in percutaneous coronary proceduresSCIAHBASI, Alessandro; FISCHETTI, Dionigi; PICCIOLO, Amedeo et al.International journal of cardiology. 2009, Vol 137, Num 3, pp 199-205, issn 0167-5273, 7 p.Article

Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases : Survey by outcome research network for evaluation of treatment results in oncologyMOSCETTI, Luca; NELLI, Fabrizio; FELICI, Alessandra et al.Cancer. 2007, Vol 109, Num 2, pp 274-281, issn 0008-543X, 8 p.Article

Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patientsGARUFI, Carlo; VANNI, Barbara; ASCHELTER, Anna Maria et al.European journal of cancer (1990). 2006, Vol 42, Num 5, pp 608-616, issn 0959-8049, 9 p.Article

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trialsBRIA, Emilio; CARBOGNIN, Luisa; SPERDUTI, Isabella et al.Cancer treatment reviews. 2014, Vol 40, Num 7, pp 847-856, issn 0305-7372, 10 p.Article

A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC)SIMONA PINO, Maria; GAMUCCI, Teresa; MANSUETO, Giovanni et al.Lung cancer. 2008, Vol 60, Num 3, pp 381-386, issn 0169-5002, 6 p.Article

Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract CancersPINO, Maria S; MILELLA, Michele; COGNETTI, Francesco et al.Oncology. 2009, Vol 76, Num 4, pp 254-261, issn 0030-2414, 8 p.Article

Pharmacokinetics of Gemcitabine at Fixed-Dose Rate Infusion in Patients with Normal and Impaired Hepatic FunctionFELICI, Alessandra; DI SEGNI, Susanna; COGNETTI, Francesco et al.Clinical pharmacokinetics. 2009, Vol 48, Num 2, pp 131-141, issn 0312-5963, 11 p.Article

Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemiaMOLICA, Stefano; VITELLI, Gaetano; MORABITO, Fortunato et al.International journal of hematology. 2008, Vol 88, Num 4, pp 374-380, issn 0925-5710, 7 p.Article

HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevantBENEVOLO, Maria; MOTTOLESE, Marcella; PIPERNO, Giulia et al.The American journal of surgical pathology. 2007, Vol 31, Num 1, pp 76-84, issn 0147-5185, 9 p.Article

Clinical features and outcome of familial chronic lymphocytic leukemiaMAURO, Francesca R; GIAMMARTINI, Elena; GENTILE, Massimo et al.Haematologica (Roma). 2006, Vol 91, Num 8, pp 1117-1120, issn 0390-6078, 4 p.Article

Pegylated liposomal doxorubicin in combination with gemcitabine : a phase II study in anthracycline-naive and anthracycline pretreated metastatic breast cancer patientsFABI, Alessandra; FERRETTI, Gianluigi; GIANNARELLI, Diana et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 615-623, issn 0344-5704, 9 p.Article

Both mucosal and cutaneous papillomaviruses are in the oral cavity but only alpha genus seems to be associated with cancerPAOLINI, Francesca; RIZZO, Consuelo; SPERDUTI, Isabella et al.Journal of clinical virology. 2013, Vol 56, Num 1, pp 72-76, issn 1386-6532, 5 p.Article

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancerNATOLI, Clara; VICI, Patrizia; DE TURSI, Michele et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 7, pp 1229-1240, issn 0171-5216, 12 p.Article

Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective studyMOSCETTI, Luca; NELLI, Fabrizio; FRANCO, Daniela et al.Investigational new drugs. 2013, Vol 31, Num 4, pp 1035-1043, issn 0167-6997, 9 p.Article

Genetic profile identification in clinically localized prostate carcinomaGALLUCCI, Michele; MEROLA, Roberta; SIMONE, Giuseppe et al.Urologic oncology. 2009, Vol 27, Num 5, pp 502-508, issn 1078-1439, 7 p.Article

Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer : Identification of an adverse prognostic profileMOTTOLESE, Marcella; ORLANDI, Giulia; CIANCIULLI, Annamaria et al.The American journal of surgical pathology. 2007, Vol 31, Num 2, pp 247-254, issn 0147-5185, 8 p.Article

Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer : a multicentric phase II studyFELICI, Alessandra; CARLINI, Paolo; SPERDUTI, Isabella et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 1, pp 59-64, issn 0344-5704, 6 p.Article

Impact of gefitinib ('Iressa') treatment on the quality of life of patients with advanced non-small-cell lung cancerGELIBTER, Alain; CERIBELLI, Anna; POLLERA, Camillo F et al.Journal of cancer research and clinical oncology. 2005, Vol 131, Num 12, pp 783-788, issn 0171-5216, 6 p.Article

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancerFABI, Alessandra; MEROLA, Roberta; VICI, Patrizia et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 6, pp 699-706, issn 1465-6566, 8 p.Article

  • Page / 2